This may indicate that increased CTLA-4 expression is associated with immunosuppression and acceleration of disease progression and metastasis, possibly mediated by tumor cell synthesis of soluble CTLA-4 [41–43]. This evidence concerns the gene CTLA4 and neoplasm.